{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05515562",
            "orgStudyIdInfo": {
                "id": "IRB00081259"
            },
            "organization": {
                "fullName": "Wake Forest University Health Sciences",
                "class": "OTHER"
            },
            "briefTitle": "Effects of Intravenous (IV) Omadacycline on Gut Microbiome",
            "officialTitle": "Effects of IV Omadacycline on Gut Microbiome",
            "therapeuticArea": [
                "Other"
            ],
            "study": "effects-of-intravenous-iv-omadacycline-on-gut-microbiome"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-03-20",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-10",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-10",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-08-23",
            "studyFirstSubmitQcDate": "2022-08-23",
            "studyFirstPostDateStruct": {
                "date": "2022-08-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Wake Forest University Health Sciences",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "University of Houston",
                    "class": "OTHER"
                },
                {
                    "name": "High Point University",
                    "class": "OTHER"
                },
                {
                    "name": "Paratek Pharmaceuticals Inc",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "Given the clinical need to improve upon current antibiotic regimens for the treatment of C. difficile infection with a particular focus on the impact of therapies on gut microbiome, this study proposes to characterize the impact of Intravenous (IV) omadacycline on gut microbiome of healthy volunteers.",
            "detailedDescription": "The plan to enroll eight healthy volunteers between the ages of 18 and 40 years and without history of cardiovascular, gastrointestinal, hepatic, or renal disease to receive 5 days of intravenous omadacycline followed by 5 days of oral omadacycline. Stool and saliva samples will be collected at pre-specified times and analyzed to characterize the impact of IV omadacycline on gut microbiome."
        },
        "conditionsModule": {
            "conditions": [
                "Microbial Colonization"
            ],
            "keywords": [
                "Gut Microbiome",
                "Clostridioides difficile"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 8,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Intravenous (IV) Omadacycline",
                    "type": "EXPERIMENTAL",
                    "description": "All participants will receive 5 days of IV omadacycline followed by 5 days of oral omadacycline",
                    "interventionNames": [
                        "Drug: Omadacycline Injection"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Omadacycline Injection",
                    "description": "All participants will receive Intravenous (IV) omadacycline",
                    "armGroupLabels": [
                        "Intravenous (IV) Omadacycline"
                    ],
                    "otherNames": [
                        "Omadacycline oral"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in gut microbiota concentrations",
                    "description": "In general, the healthy volunteer analyses will assess changes in total and species-specific microbiota over time as well as changes in microbial diversity.",
                    "timeFrame": "Day 31"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* 18-40 years of age\n* Willing and able to comply with all study procedures\n* Considered healthy without history of cardiovascular, gastrointestinal, hepatic, or renal disease\n* males or females - females of child bearing potential must agree to use a highly effective contraception during the study and for at least 7 days after the last dose of omadacycline\n\nExclusion Criteria:\n\n* Consumed probiotics within 30 days before enrollment\n* Consumed antibiotics within 90 days prior to enrollment\n* Known hypersensitivity to omadacycline or tetracycline-class antibiotics\n* pregnant or breastfeeding\n* in the opinion of the investigator is experiencing signs or symptoms of acute illness that increase the risk of adverse effects from participating in the study\n* previously participated in the study",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "40 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Yolanda Belin",
                    "role": "CONTACT",
                    "phone": "336-716-3720",
                    "email": "ybelin@wakehealth.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "John C Williamson",
                    "affiliation": "Wake Forest University Health Sciences",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Wake Forest Baptist Health",
                    "status": "RECRUITING",
                    "city": "Winston-Salem",
                    "state": "North Carolina",
                    "zip": "27157",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "John C Williamson, PharmD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.09986,
                        "lon": -80.24422
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "IPD that underlie the results reported in this article, after deidentification",
            "infoTypes": [
                "STUDY_PROTOCOL"
            ],
            "timeFrame": "Beginning 6 months following article publication and ending 36 months following article publication",
            "accessCriteria": "Researchers who provide a methodologically sound proposal"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003141",
                    "term": "Communicable Diseases"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10283",
                    "name": "Infections",
                    "asFound": "Microbial Colonization",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "asFound": "Microbial Colonization",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        }
    },
    "hasResults": false
}